Bellicum Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 31, 2022 17:49 ET
|
Bellicum Pharmaceuticals, Inc.
HOUSTON, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for cancers, today announced equity...
Microfluidics Global Market to Reach $10.79 Billion by 2026 at a CAGR of 11.99%
October 27, 2022 08:23 ET
|
Research and Markets
Dublin, Oct. 27, 2022 (GLOBE NEWSWIRE) -- The "Microfluidics Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.The global microfluidics market is expected to...
AGC Biologics Receives Excellence in Innovation and Leadership by Italy's Leading Business News Channel Le Fonti
October 27, 2022 03:00 ET
|
AGC Biologics
Milan, Italy, Oct. 27, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced it received the...
T-Cell Therapy Market Size to Hit $21+ Billion with Booming CAGR Value of 20.7% by 2028 | The Insight Partners
October 20, 2022 09:22 ET
|
The Insight Partners
New York, Oct. 20, 2022 (GLOBE NEWSWIRE) -- According to The Insight Partners latest study on "T-cell Therapy Market Size, Share, Trends, Growth Strategy and Forecast to 2028 – COVID-19 Impact and...
TVAX Biomedical Announces Receipt of $2 Million FDA Orphan Products Grant for Glioblastoma Study
October 18, 2022 10:07 ET
|
TVAX Biomedical
OLATHE, Kan., Oct. 18, 2022 (GLOBE NEWSWIRE) -- TVAX Biomedical (TVAX) is a cancer immunotherapy company that is moving into its pivotal glioblastoma study for FDA regulatory approval. In September...
invIOs to present data from clinical stage Cbl-b program at SITC 2022
October 18, 2022 02:00 ET
|
invIOs GmbH
VIENNA, Austria, Oct. 18, 2022 (GLOBE NEWSWIRE) -- invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, today announces that two abstracts on its...
Global Live Cell Imaging Market Report (2022 to 2027) - Deep Learning & Artificial Intelligence Enhance Live-Cell Imaging Techniques Presents Opportunities
October 17, 2022 07:48 ET
|
Research and Markets
Dublin, Oct. 17, 2022 (GLOBE NEWSWIRE) -- The "Live Cell Imaging Market - Global Outlook & Forecast Market 2022-2027" report has been added to ResearchAndMarkets.com's offering.Live cell...
Cell Cryopreservation Global Market Report 2022: Featuring General Electric, Thermo Fisher, Merck, BioLifeSolutions & More
October 13, 2022 08:23 ET
|
Research and Markets
Dublin, Oct. 13, 2022 (GLOBE NEWSWIRE) -- The "Cell Cryopreservation Market, by Product Type, by Application, by End User, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 -...
invIOs to present at upcoming industry and investor conferences
October 11, 2022 02:00 ET
|
invIOs GmbH
VIENNA, Austria, Oct. 11, 2022 (GLOBE NEWSWIRE) -- invIOs GmbH (“invIOs”), a privately held biotechnology company developing novel therapies for cancer, today announces its participation at three...
Immatics Announces $110 Million Underwritten Offering of Ordinary Shares
October 10, 2022 07:37 ET
|
https://immatics.com/
Houston, Texas and Tuebingen, Germany, October 10, 2022 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T...